CVS Health will now deliver prescriptions to your home

Henrietta Strickland
June 21, 2018

Other hedge funds and other institutional investors also recently modified their holdings of the company.

The drugstore chain has tried to position itself as more of a health care provider. The firm owned 110,110 shares of the pharmacy operator's stock after acquiring an additional 104,471 shares during the period. Walter & Keenan Financial Consulting Co. The stock grabbed 113 new institutional investments totaling 10,227,703 shares while 149 institutional investors sold out their entire positions totaling 9,844,304 shares. Wealthcare Advisory Partners LLC boosted its position in CVS Health by 330.3% during the third quarter. The Manufacturers Life Insurance Company now owns 4,818,244 shares of the pharmacy operator's stock valued at $349,322,000 after purchasing an additional 2,889,561 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of CVS Health by 7,225.3% during the fourth quarter. Finally, Mission Wealth Management LP boosted its position in shares of CVS Health by 28.3% during the 4th quarter. The firm owned 18,633 shares of the pharmacy operator's stock after selling 73,391 shares during the period.

The company now has an insider ownership of 0.1 Percent and Institutional ownership of 86 Percent. Shares for $619,900 were bought by BROWN C DAVID II on Friday, May 4.

In the transaction dated December 21, 2017, the great number of shares disposed came courtesy the EVP and Chief HR Officer; Bisaccia Lisa disposed a total of 29,445 shares at an average price of $75, amounting to approximately $2,208,375. Following the acquisition, the director now directly owns 101,252 shares of the company's stock, valued at approximately $6,276,611.48. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. ETRADE Capital Management LLC's holdings in CVS Health were worth $5,303,000 as of its most recent filing with the SEC.

CVS Pharmacy, the retail division of CVS Health (CVS), today announced that prescription delivery is now available from CVS Pharmacy locations nationwide. They issued a "buy" rating and a $91.00 target price on the stock. Leerink Swann set a $85.00 target price on CVS Health and gave the company a "buy" rating in a research report on Tuesday, April 10th.

Among 12 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 2 Hold. The company has an average rating of "Buy" and a consensus price target of $86.27. The stock has been active on the tape, now trading at $67.74, down from yesterday's close by -3.35%. 11,018,280 shares of the stock were exchanged, compared to its average volume of 8,801,772.

When we see the company's Volatility, it now has a monthly volatility of 2.23% and weekly volatility of 2.64%. The stock has a market capitalization of $71.26 billion, a PE ratio of 11.88, a P/E/G ratio of 0.98 and a beta of 1.00.

CVS Health Corporation (NYSE:CVS) touched its 1-Year High price of $84.00 on 09/19/17 and its 1-Year Low price of $60.14 on 03/27/18.

CVS Health Corporation (NYSE:CVS) has declined 13.06% since June 17, 2017 and is downtrending. The pharmacy operator reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.09.

Analysts believe that the company has the potential to earn average revenue of $46.35 Billion for the current quarter.

CVS Health Corporation (NYSE:CVS) gross margin percentage stands at 15.5% while its operating margin for the past trailing twelve month is 5.2 percent and its overall profit margin (ttm) is 3.6 Percent. The company's revenue for the quarter was up 2.6% compared to the same quarter last year. equities research analysts forecast that CVS Health Corp will post 6.98 EPS for the current year.

Other reports by Click Lancashire

Discuss This Article